Colon cancer is one of the most prevalent forms of cancer affecting both men and women. In the U.S. it’s also the second most common cause of cancer-related deaths. According to the American Cancer Society, it is “expected to cause about 51,020 deaths during 2019.”
The risk of developing colorectal cancer, they explain, “is about 1 in 22 for men and 1 in 24 for women.”
Unfortunately, many people who should get tested for colon cancer simply don’t. However, there’s now research that shows screenings can effectively be conducted at home.
A new review proves that at-home tests can be used to screen for colon cancer in those with average-risk factors.
Researchers combined results from over 30 studies regarding fecal immunochemical tests (FIT). What they found was that while not quite as accurate as a colonoscopy, it’s still an acceptable substitute.
The FIT is also a much less-invasive alternative to a colonoscopy. It works by testing a stool sample for traces of blood not visible to the human eye. When blood is found in a person’s stool, it can be a sign of a colon polyp or colon cancer.
A positive FIT, of course, could very well necessitate a follow-up colonoscopy.
When it comes to colon cancer, it’s important to know your risk factors, including family history. Those with inflammatory bowel disease or hereditary risks should still receive colonoscopies.
Additionally, the American Cancer Society has lowered the suggested age at which average-risk people should receive regular screenings. They now suggest them for anyone over the age of 45 (down from 50).
Considering only about 65 percent of people who should get screenings do, an at-home FIT could be quite significant. What’s more, is that colon cancer is actually one of the most curable types of cancer when detected early on.
Of course, FITs should be conducted annually, whereas colonoscopies are typically not conducted anywhere near as frequently.
